SYMPOSIUM 7: Creative Solutions for Global Challenges in Fentanyl Monitoring and Toxicology
Tracks
Track 3
| Monday, September 22, 2025 |
| 2:00 PM - 3:30 PM |
| Grand Copthorne Waterfront Hotel - Waterfront Ballroom II |
Details
With the rise in fentanyl-related toxicity and overdose cases worldwide, healthcare systems are grappling with unique issues surrounding accurate monitoring, effective treatment, and prevention.
The symposium will focus on emerging technologies, collaborative international approaches, and novel intervention strategies for better management and reduction of fentanyl-related harm.
Session 1: Advanced Monitoring Technologies for Fentanyl Detection and Management
• Discuss the latest advancements in TDM technologies for real-time fentanyl monitoring, including point-of-care devices, biosensors, and wearable tech.
• Speakers will address the benefits and challenges of these technologies, especially for high-risk patients.
Session 2: Addressing Illicit Fentanyl in Forensic Toxicology and Public Health Surveillance
• Examine the growing impact of illicit fentanyl in toxicology and its burden on public health, including laboratory strategies to detect new analogs.
• Emphasis will be on global data-sharing and best practices to monitor and address synthetic opioid crises.
Session 3: Innovative Solutions for Emergency Response and Overdose Prevention
• Discuss novel interventions in fentanyl overdose response, such as next-generation naloxone, community-level interventions, and law enforcement collaborations.
• International experts will highlight successful public health initiatives and legislative models.
Speaker
A/Prof Bridin Murnion
St. Vincent's Hospital. St. Vincent's Clinical School
Overview of opioid management in the clinical space: pain, overdose and addiction
Biography
Bridin is a Senior Staff Specialist in Clinical Pharmacology and Toxicology at St. Vincent's Hospital and a Conjoint Associate Professor at St. Vincent's Clinical School. Their research focuses on neuropsychopharmacology, drugs of abuse, opioid use in pain and dependence, and medicines use in priority populations. Their vision is to optimize the quality use of medicines in priority populations.
Dr Guillaume Drevin
Pathologie, Centre Hospitalier Universitaire d’Angers
Leveraging pharmacogenetics for tailored fentanyl overdose prevention and response
Biography
Dr Lei Fu
Sunnybrook Health Sciences Centre, University of Toronto
Detection and monitoring fentanyl use and misuse in patients presented in emergency room and out-patient substance use clinic
Biography
Manuela Neuman
Banting Institute
Fentanyl use and misuse – forensic cases, laboratory biomarkers
Biography
Session chair
Danijela Kocic
St. Vincent's Hospital
Ofelia Noceti
National Center for Liver Transplantation and Liver Diseases, Uruguay
